Spire Wealth Management’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.6K Buy
+300
New +$12.6K ﹤0.01% 1480
2022
Q1
Sell
-62
Closed -$3K 2884
2021
Q4
$3K Buy
+62
New +$2.74K ﹤0.01% 2726
2021
Q2
Sell
-62
Closed -$3K 2971
2021
Q1
$3K Buy
+62
New +$3.57K ﹤0.01% 2782

Other funds holding VCYT

Spire Wealth Management's VCYT Position: Q2 2026 in Review

Spire Wealth Management opened a new position in Veracyte (VCYT) in Q2 2026: 300 shares worth $17.6K. The stake represents ﹤0.01% of the portfolio and ranks #1480 among its holdings. This is a return to the name: Spire Wealth Management previously reported a position in VCYT as recently as Q4 2021.

Spire Wealth Management first reported a position in VCYT in Q1 2021 and has held it in 3 quarters since. 24 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Spire Wealth Management held 300 shares of Veracyte worth $17.6K as of Q2 2026.
  • Veracyte was a new Spire Wealth Management position in Q2 2026.
  • Veracyte made up ﹤0.01% of Spire Wealth Management's portfolio in Q2 2026, its #1480 holding.
  • Spire Wealth Management first reported a position in Veracyte in Q1 2021 and has held it in 3 quarters since.
  • 24 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Spire Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.